Bruker Stock Price, News & Analysis (NASDAQ:BRKR)

$32.10 -0.20 (-0.62 %)
(As of 02/19/2018 03:16 AM ET)
Previous Close$32.10
Today's Range$31.90 - $32.44
52-Week Range$21.83 - $36.53
Volume262,895 shs
Average Volume597,693 shs
Market Capitalization$4.99 billion
P/E Ratio65.51
Dividend Yield0.50%
Beta1.05

About Bruker (NASDAQ:BRKR)

Bruker logoBruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools. The Bruker CALID segment designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive detection products. The Bruker Nano segment designs, manufactures and distributes spectroscopy and microscopy instruments. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices. It also focuses on nanomechanical testing instruments.

Receive BRKR News and Ratings via Email

Sign-up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
SymbolNASDAQ:BRKR
CUSIP11679410
Phone978-663-3660

Debt

Debt-to-Equity Ratio0.65%
Current Ratio2.60%
Quick Ratio1.60%

Price-To-Earnings

Trailing P/E Ratio65.5102040816327
Forward P/E Ratio23.43
P/E Growth2.13

Sales & Book Value

Annual Sales$1.77 billion
Price / Sales2.83
Cash Flow$1.54 per share
Price / Cash20.88
Book Value$4.32 per share
Price / Book7.43

Profitability

Trailing EPS$0.49
Net Income$78.60 million
Net Margins4.45%
Return on Equity26.58%
Return on Assets10.39%

Miscellaneous

Employees6,000
Outstanding Shares155,560,000

Bruker (NASDAQ:BRKR) Frequently Asked Questions

What is Bruker's stock symbol?

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

How often does Bruker pay dividends? What is the dividend yield for Bruker?

Bruker announced a quarterly dividend on Monday, November 13th. Stockholders of record on Monday, December 4th will be paid a dividend of $0.04 per share on Friday, December 22nd. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.50%. The ex-dividend date of this dividend is Friday, December 1st. View Bruker's Dividend History.

How will Bruker's stock buyback program work?

Bruker declared that its board has approved a share buyback plan on Sunday, June 4th 2017, which permits the company to buyback $225,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to purchase shares of its stock through open market purchases. Stock buyback plans are often an indication that the company's board believes its stock is undervalued.

How were Bruker's earnings last quarter?

Bruker Co. (NASDAQ:BRKR) issued its quarterly earnings data on Thursday, February, 8th. The medical research company reported $0.51 EPS for the quarter, beating the Zacks' consensus estimate of $0.49 by $0.02. The medical research company earned $530.50 million during the quarter, compared to the consensus estimate of $506.74 million. Bruker had a return on equity of 26.58% and a net margin of 4.45%. The firm's revenue was up 12.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.46 earnings per share. View Bruker's Earnings History.

When will Bruker make its next earnings announcement?

Bruker is scheduled to release their next quarterly earnings announcement on Wednesday, May, 2nd 2018. View Earnings Estimates for Bruker.

What guidance has Bruker issued on next quarter's earnings?

Bruker updated its FY18 earnings guidance on Thursday, February, 8th. The company provided earnings per share guidance of $1.34 to $1.38 for the period, compared to the Thomson Reuters consensus estimate of $1.34. The company issued revenue guidance of $1.889 billion, compared to the consensus revenue estimate of $1.82 billion.

Where is Bruker's stock going? Where will Bruker's stock price be in 2018?

15 Wall Street analysts have issued twelve-month target prices for Bruker's stock. Their forecasts range from $24.00 to $42.00. On average, they expect Bruker's stock price to reach $32.08 in the next year. View Analyst Ratings for Bruker.

Who are some of Bruker's key competitors?

Who are Bruker's key executives?

Bruker's management team includes the folowing people:

  • Frank H. Laukien Ph.D., Chairman of the Board, President, Chief Executive Officer (Age 57)
  • Anthony L. Mattacchione, Chief Financial Officer, Senior Vice President (Age 54)
  • Juergen Srega, President of Bruker CALID Group and Bruker Daltonics Division (Age 62)
  • Mark Robert Munch Ph.D., Executive Vice President - President of Bruker Nano Group and Bruker Nano Surfaces Division (Age 55)
  • William A. Linton, Lead Independent Director (Age 69)
  • Joerg C. Laukien, Director (Age 63)
  • Cynthia M. Friend Ph.D., Independent Director (Age 62)
  • Marc A. Kastner Ph.D., Independent Director (Age 71)
  • Richard D. Kniss, Independent Director (Age 76)

Who owns Bruker stock?

Bruker's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Acadian Asset Management LLC (3.36%), BlackRock Inc. (3.33%), OppenheimerFunds Inc. (1.96%), Alliancebernstein L.P. (1.30%), Millennium Management LLC (1.25%) and Victory Capital Management Inc. (0.94%). Company insiders that own Bruker stock include Frank H Laukien, Ingen Chris Van, Joerg C Laukien, Mark Munch, Richard A Packer, Richard Kniss and Wolf-Dieter Emmerich. View Institutional Ownership Trends for Bruker.

Who sold Bruker stock? Who is selling Bruker stock?

Bruker's stock was sold by a variety of institutional investors in the last quarter, including Boston Partners, Victory Capital Management Inc., Goldman Sachs Group Inc., Millennium Management LLC, Citadel Advisors LLC, OppenheimerFunds Inc., Cambiar Investors LLC and Two Sigma Advisers LP. Company insiders that have sold Bruker company stock in the last year include Ingen Chris Van, Mark Munch and Richard Kniss. View Insider Buying and Selling for Bruker.

Who bought Bruker stock? Who is buying Bruker stock?

Bruker's stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Acadian Asset Management LLC, Sensato Investors LLC, Mackenzie Financial Corp, Renaissance Technologies LLC, Arrowstreet Capital Limited Partnership, Amundi Pioneer Asset Management Inc. and Fuller & Thaler Asset Management Inc.. Company insiders that have bought Bruker stock in the last two years include Frank H Laukien and Richard A Packer. View Insider Buying and Selling for Bruker.

How do I buy Bruker stock?

Shares of Bruker can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bruker's stock price today?

One share of Bruker stock can currently be purchased for approximately $32.10.

How big of a company is Bruker?

Bruker has a market capitalization of $4.99 billion and generates $1.77 billion in revenue each year. The medical research company earns $78.60 million in net income (profit) each year or $0.49 on an earnings per share basis. Bruker employs 6,000 workers across the globe.

How can I contact Bruker?

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at [email protected]


MarketBeat Community Rating for Bruker (BRKR)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  347 (Vote Outperform)
Underperform Votes:  414 (Vote Underperform)
Total Votes:  761
MarketBeat's community ratings are surveys of what our community members think about Bruker and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Bruker (NASDAQ:BRKR) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.072.132.072.17
Ratings Breakdown: 2 Sell Rating(s)
10 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
9 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
9 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
8 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $32.08$31.83$28.90$26.25
Price Target Upside: 6.10% upside9.02% downside13.32% downside10.04% downside

Bruker (NASDAQ:BRKR) Consensus Price Target History

Price Target History for Bruker (NASDAQ:BRKR)

Bruker (NASDAQ:BRKR) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/9/2018Morgan StanleyLower Price TargetEqual Weight -> Equal Weight$35.00 -> $32.00LowView Rating Details
2/9/2018Leerink SwannBoost Price TargetMarket Perform -> Market Perform$32.00 -> $34.00HighView Rating Details
1/5/2018BTIG ResearchInitiated CoverageBuy -> Buy$42.00HighView Rating Details
1/3/2018Evercore ISIInitiated CoverageIn-Line$36.00LowView Rating Details
12/21/2017CowenReiterated RatingHold$35.00LowView Rating Details
11/3/2017CitigroupBoost Price TargetNeutral$29.00 -> $34.00N/AView Rating Details
11/3/2017Bank of AmericaUpgradeUnderperform -> Neutral$34.00N/AView Rating Details
11/3/2017JPMorgan Chase & Co.UpgradeUnderweight -> Neutral$28.00N/AView Rating Details
9/26/2017Goldman Sachs GroupReiterated RatingSell -> Sell$24.00LowView Rating Details
7/17/2017BarclaysReiterated RatingEqual Weight$26.00 -> $30.00LowView Rating Details
7/12/2017Wells Fargo & CoDowngradeMarket Perform -> UnderperformMediumView Rating Details
5/15/2017Jefferies GroupReiterated RatingBuy$29.00N/AView Rating Details
5/15/2017Deutsche BankBoost Price TargetHold$25.00 -> $27.00N/AView Rating Details
4/27/2017Cleveland ResearchUpgradeNeutral -> BuyHighView Rating Details
3/27/2017Janney Montgomery ScottDowngradeBuy -> NeutralLowView Rating Details
2/14/2017Cantor FitzgeraldSet Price TargetBuy$28.00N/AView Rating Details
8/3/2016MizuhoLower Price TargetNeutral$28.00 -> $23.00N/AView Rating Details
3/14/2016Stifel NicolausBoost Price TargetBuy$25.00 -> $32.00N/AView Rating Details
(Data available from 2/19/2016 forward)

Earnings

Bruker (NASDAQ:BRKR) Earnings History and Estimates Chart

Earnings by Quarter for Bruker (NASDAQ:BRKR)

Bruker (NASDAQ BRKR) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/1/2018$0.25N/AView Earnings Details
2/8/2018Q4 2017$0.49$0.51$506.74 million$530.50 millionViewListenView Earnings Details
11/2/2017Q3 2017$0.27$0.29$415.45 million$435.60 millionViewN/AView Earnings Details
8/3/2017Q2 2017$0.20$0.23$384.75 million$414.90 millionViewN/AView Earnings Details
5/3/2017Q1 2017$0.19$0.19$372.59 million$384.90 millionViewN/AView Earnings Details
2/13/2017Q416$0.37$0.46$464.49 million$470.30 millionViewN/AView Earnings Details
11/2/2016Q316$0.20$0.32$394.14 million$393.90 millionViewN/AView Earnings Details
8/2/2016Q216$0.20$0.20$409.57 million$371.70 millionViewN/AView Earnings Details
5/4/2016Q116$0.15$0.21$360.37 million$375.40 millionViewN/AView Earnings Details
2/10/2016Q415$0.27$0.38$469.98 million$478.20 millionViewN/AView Earnings Details
11/4/2015Q315$0.13$0.19$373.65 million$396.10 millionViewN/AView Earnings Details
8/5/2015Q215$0.17$0.19$391.87 million$396.00 millionViewN/AView Earnings Details
5/6/2015Q115$0.10$0.14$369.80 million$353.50 millionViewN/AView Earnings Details
2/19/2015Q414$0.29$0.30$515.50 million$508.00 millionViewN/AView Earnings Details
11/6/2014Q314$0.15$0.14$436.30 million$419.80 millionViewN/AView Earnings Details
8/6/2014Q214$0.19$0.21$457.90 million$457.40 millionViewN/AView Earnings Details
5/7/2014Q114$0.09$0.11$402.04 million$423.70 millionViewN/AView Earnings Details
2/18/2014Q413$0.22$0.31$452.14 million$552.10 millionViewListenView Earnings Details
11/1/2013Q313$0.22$0.20$452.40 million$439.00 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.14$0.18$426.39 million$454.90 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.14$0.08$416.76 million$393.40 millionViewListenView Earnings Details
2/19/2013Q4 2012$0.24$0.28$483.65 million$517.30 millionViewListenView Earnings Details
11/5/2012Q312$0.15$0.28$421.39 million$447.80 millionViewN/AView Earnings Details
7/31/2012$0.12$0.12ViewN/AView Earnings Details
5/1/2012$0.12$0.14ViewN/AView Earnings Details
2/22/2012$0.29$0.31ViewN/AView Earnings Details
10/27/2011$0.22$0.23ViewN/AView Earnings Details
8/3/2011$0.21$0.20ViewN/AView Earnings Details
4/28/2011$0.15$0.14ViewN/AView Earnings Details
2/23/2011$0.27$0.27ViewN/AView Earnings Details
10/28/2010Q3 2010$0.12$0.19ViewN/AView Earnings Details
7/28/2010Q2 2010$0.12$0.15ViewN/AView Earnings Details
4/29/2010Q1 2010$0.08$0.10ViewN/AView Earnings Details
2/25/2010Q4 2009$0.20$0.27ViewN/AView Earnings Details
10/29/2009Q3 2009$0.07$0.10ViewN/AView Earnings Details
7/29/2009Q2 2009$0.07$0.08ViewN/AView Earnings Details
4/30/2009Q1 2009$0.05$0.05ViewN/AView Earnings Details
3/3/2009Q4 2008$0.12$0.18ViewN/AView Earnings Details
10/30/2008Q3 2008$0.12$0.11ViewN/AView Earnings Details
7/31/2008Q2 2008$0.09$0.13ViewN/AView Earnings Details
5/5/2008Q1 2008$0.06$0.05ViewN/AView Earnings Details
3/17/2008Q4 2007$0.11$0.26ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Bruker (NASDAQ:BRKR) Earnings Estimates

2018 EPS Consensus Estimate: $1.33
2019 EPS Consensus Estimate: $1.48
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20183$0.22$0.30$0.25
Q2 20183$0.26$0.32$0.28
Q3 20183$0.32$0.34$0.33
Q4 20183$0.40$0.56$0.47
Q1 20191$0.26$0.26$0.26
Q2 20191$0.28$0.28$0.28
Q3 20191$0.34$0.34$0.34
Q4 20191$0.60$0.60$0.60
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Bruker (NASDAQ:BRKR) Dividend Information

Most Recent Dividend:12/22/2017
Annual Dividend:$0.16
Dividend Yield:0.50%
Payout Ratio:32.65% (Trailing 12 Months of Earnings)
11.68% (Based on This Year's Estimates)
10.53% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Bruker (NASDAQ:BRKR)

Bruker (NASDAQ:BRKR) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
11/13/2017quarterly$0.040.49%12/1/201712/4/201712/22/2017
8/14/2017quarterly$0.040.57%8/31/20179/5/20179/22/2017
5/15/2017quarterly$0.040.61%6/1/20176/5/20176/23/2017
2/21/2017quarterly$0.040.65%3/6/20173/8/20173/24/2017
11/15/2016quarterly$0.040.69%12/1/201612/5/201612/23/2016
8/9/2016quarterly$0.040.72%9/1/20169/6/20169/23/2016
5/18/2016quarterly$0.040.61%6/2/20166/6/20166/24/2016
2/22/2016Quarterly$0.043/2/20163/4/20163/24/2016
(Data available from 1/1/2013 forward)

Insider Trades

Bruker (NASDAQ BRKR) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 35.20%
Institutional Ownership Percentage: 64.78%
Insider Trades by Quarter for Bruker (NASDAQ:BRKR)
Insider Trades by Quarter for Bruker (NASDAQ:BRKR)

Bruker (NASDAQ BRKR) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/13/2017Mark MunchVPSell21,061$29.97$631,198.1760,524View SEC Filing  
8/10/2017Frank H LaukienCEOBuy2,335$27.39$63,955.6537,791,386View SEC Filing  
6/14/2017Ingen Chris VanDirectorSell19,900$28.03$557,797.0014,577View SEC Filing  
6/13/2017Richard KnissDirectorSell24,000$28.23$677,520.0046,753View SEC Filing  
6/8/2017Mark MunchVPSell73,724$27.62$2,036,256.88106,602View SEC Filing  
5/19/2017Frank H LaukienCEOBuy3,200$26.13$83,616.0037,789,051View SEC Filing  
5/18/2017Frank H LaukienCEOBuy73,000$26.22$1,914,060.0037,750,851View SEC Filing  
5/16/2017Frank H LaukienCEOBuy1,920$25.88$49,689.6037,712,851View SEC Filing  
3/17/2017Frank H LaukienCEOBuy4,300$23.34$100,362.0037,710,931View SEC Filing  
3/13/2017Frank H LaukienCEOBuy2,300$23.74$54,602.0037,706,631View SEC Filing  
12/15/2016Frank H LaukienCEOBuy4,725$21.22$100,264.5037,704,331View SEC Filing  
12/13/2016Ingen Chris VanDirectorSell20,000$22.29$445,800.005,000View SEC Filing  
11/25/2016Frank H LaukienCEOBuy2,124$22.90$48,639.6037,699,606View SEC Filing  
8/10/2016Richard A PackerDirectorBuy10,000$21.97$219,700.0022,500View SEC Filing  
8/5/2016Frank H LaukienCEOBuy4,500$22.17$99,765.0037,658,733View SEC Filing  
6/14/2016Frank H LaukienCEOBuy4,174$23.95$99,967.3037,654,233View SEC Filing  
6/6/2016Joerg C LaukienDirectorSell2,000,000$25.65$51,300,000.0015,208,795View SEC Filing  
5/9/2016Wolf-Dieter EmmerichDirectorSell21,000$27.35$574,350.003,000View SEC Filing  
6/15/2015Frank H LaukienCEOBuy1,000,000$19.50$19,500,000.00View SEC Filing  
6/11/2015Frank H LaukienCEOBuy5,901$20.31$119,849.31View SEC Filing  
6/11/2015Stephen W FesikDirectorSell15,000$20.48$307,200.00View SEC Filing  
3/17/2015Charles F Wagner JrCFOSell19,000$18.97$360,430.00View SEC Filing  
3/5/2015Richard A PackerDirectorBuy15,000$19.00$285,000.00View SEC Filing  
2/25/2015Frank H LaukienCEOBuy5,271$18.95$99,885.45View SEC Filing  
12/14/2012Frank H LaukienCEOBuy50,000$14.68$734,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Bruker (NASDAQ BRKR) News Headlines

Source:
DateHeadline
Bruker Co. (BRKR) to Post Q1 2018 Earnings of $0.23 Per Share, William Blair ForecastsBruker Co. (BRKR) to Post Q1 2018 Earnings of $0.23 Per Share, William Blair Forecasts
www.americanbankingnews.com - February 14 at 8:44 AM
The Bruker MALDI Biotyper Solution Receives AOAC International Approvals for Two Official Methods of Analysis (OMA) in Food MicrobiologyThe Bruker MALDI Biotyper Solution Receives AOAC International Approvals for Two Official Methods of Analysis (OMA) in Food Microbiology
finance.yahoo.com - February 14 at 7:51 AM
Bruker Co. (BRKR) Given Average Rating of "Hold" by BrokeragesBruker Co. (BRKR) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - February 13 at 9:24 PM
Zacks: Brokerages Expect Bruker Co. (BRKR) Will Announce Quarterly Sales of $410.24 MillionZacks: Brokerages Expect Bruker Co. (BRKR) Will Announce Quarterly Sales of $410.24 Million
www.americanbankingnews.com - February 13 at 8:30 AM
Zacks: Analysts Expect Bruker Co. (BRKR) Will Announce Earnings of $0.26 Per ShareZacks: Analysts Expect Bruker Co. (BRKR) Will Announce Earnings of $0.26 Per Share
www.americanbankingnews.com - February 11 at 1:12 AM
Bruker (BRKR) Price Target Raised to $34.00Bruker (BRKR) Price Target Raised to $34.00
www.americanbankingnews.com - February 10 at 1:28 PM
Bruker (BRKR) Downgraded to "Hold" at BidaskClubBruker (BRKR) Downgraded to "Hold" at BidaskClub
www.americanbankingnews.com - February 10 at 12:12 PM
Morgan Stanley Cuts Bruker (BRKR) Price Target to $32.00Morgan Stanley Cuts Bruker (BRKR) Price Target to $32.00
www.americanbankingnews.com - February 9 at 8:24 PM
Bruker reports 4Q lossBruker reports 4Q loss
finance.yahoo.com - February 9 at 3:40 PM
Bruker Reports Fourth Quarter and Fiscal Year 2017 Financial ResultsBruker Reports Fourth Quarter and Fiscal Year 2017 Financial Results
finance.yahoo.com - February 9 at 3:40 PM
Bruker (BRKR) Beats on Q4 Earnings & Revenues, Issues ViewBruker (BRKR) Beats on Q4 Earnings & Revenues, Issues View
finance.yahoo.com - February 9 at 3:40 PM
Bruker Corporation to Present at the LEERINK Partners 7th Annual Global Healthcare ConferenceBruker Corporation to Present at the LEERINK Partners 7th Annual Global Healthcare Conference
www.prnewswire.com - February 9 at 7:31 AM
Bruker (BRKR) Issues Quarterly  Earnings Results, Beats Estimates By $0.02 EPSBruker (BRKR) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS
www.americanbankingnews.com - February 8 at 9:28 PM
Bruker (BRKR) Updates FY18 Earnings GuidanceBruker (BRKR) Updates FY18 Earnings Guidance
www.americanbankingnews.com - February 8 at 6:02 PM
When Should You Buy Bruker Corporation (NASDAQ:BRKR)?When Should You Buy Bruker Corporation (NASDAQ:BRKR)?
finance.yahoo.com - February 8 at 3:31 PM
Bruker (BRKR) to Release Earnings on ThursdayBruker (BRKR) to Release Earnings on Thursday
www.americanbankingnews.com - February 1 at 1:38 AM
$507.49 Million in Sales Expected for Bruker Co. (BRKR) This Quarter$507.49 Million in Sales Expected for Bruker Co. (BRKR) This Quarter
www.americanbankingnews.com - January 27 at 10:36 AM
Bruker Announces Date and Time of Fourth Quarter 2017 Earnings Release and WebcastBruker Announces Date and Time of Fourth Quarter 2017 Earnings Release and Webcast
finance.yahoo.com - January 26 at 7:36 AM
 Analysts Expect Bruker Co. (BRKR) Will Post Earnings of $0.49 Per Share Analysts Expect Bruker Co. (BRKR) Will Post Earnings of $0.49 Per Share
www.americanbankingnews.com - January 25 at 1:22 AM
Bruker Co. (BRKR) Given Average Rating of "Hold" by AnalystsBruker Co. (BRKR) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - January 20 at 12:02 AM
What Are Accelerate Diagnostics’ Key Strengths?What Are Accelerate Diagnostics’ Key Strengths?
finance.yahoo.com - January 15 at 9:22 AM
Does Accelerate Diagnostics’ Financial Performance Bode Well?Does Accelerate Diagnostics’ Financial Performance Bode Well?
finance.yahoo.com - January 15 at 9:22 AM
What Analysts Recommend for Accelerate Diagnostics and PeersWhat Analysts Recommend for Accelerate Diagnostics and Peers
finance.yahoo.com - January 12 at 9:31 AM
$506.92 Million in Sales Expected for Bruker Co. (BRKR) This Quarter$506.92 Million in Sales Expected for Bruker Co. (BRKR) This Quarter
www.americanbankingnews.com - January 9 at 2:36 AM
Bruker (BRKR) Stock Rating Upgraded by Zacks Investment ResearchBruker (BRKR) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - January 7 at 10:32 PM
Zacks: Brokerages Expect Bruker Co. (BRKR) Will Announce Earnings of $0.49 Per ShareZacks: Brokerages Expect Bruker Co. (BRKR) Will Announce Earnings of $0.49 Per Share
www.americanbankingnews.com - January 7 at 9:28 PM
Bruker (BRKR) Now Covered by BTIG ResearchBruker (BRKR) Now Covered by BTIG Research
www.americanbankingnews.com - January 7 at 7:36 AM
Bruker (BRKR) Receives New Coverage from Analysts at Evercore ISIBruker (BRKR) Receives New Coverage from Analysts at Evercore ISI
www.americanbankingnews.com - January 3 at 10:02 PM
Lifshitz & Miller LLP Announces Investigation of Alteryx, Inc., Array BioPharma Inc., Bruker Corporation, Eagle Bancorp, Inc., Omega Healthcare Investors, Inc., Otsuka Holdings Co., Ltd., Tivity Health, Inc. and Triangle Capital CorporationLifshitz & Miller LLP Announces Investigation of Alteryx, Inc., Array BioPharma Inc., Bruker Corporation, Eagle Bancorp, Inc., Omega Healthcare Investors, Inc., Otsuka Holdings Co., Ltd., Tivity Health, Inc. and Triangle Capital Corporation
finance.yahoo.com - December 28 at 3:56 PM
Bruker Co. (BRKR) Receives Consensus Rating of "Hold" from AnalystsBruker Co. (BRKR) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - December 26 at 12:06 AM
Bruker Co. (BRKR) Expected to Announce Quarterly Sales of $506.92 MillionBruker Co. (BRKR) Expected to Announce Quarterly Sales of $506.92 Million
www.americanbankingnews.com - December 24 at 7:04 AM
$0.49 Earnings Per Share Expected for Bruker Co. (BRKR) This Quarter$0.49 Earnings Per Share Expected for Bruker Co. (BRKR) This Quarter
www.americanbankingnews.com - December 22 at 3:48 PM
Bruker (BRKR) Given Hold Rating at CowenBruker (BRKR) Given Hold Rating at Cowen
www.americanbankingnews.com - December 21 at 11:22 AM
ETFs with exposure to Bruker Corp. : December 19, 2017ETFs with exposure to Bruker Corp. : December 19, 2017
finance.yahoo.com - December 19 at 5:23 PM
Wired News – Bruker Announces 10-Year Partnership with Metropolitan Museum of Art to Advance Novel Analytical TechnologiesWired News – Bruker Announces 10-Year Partnership with Metropolitan Museum of Art to Advance Novel Analytical Technologies
finance.yahoo.com - December 15 at 9:50 AM
Brukers (BRKR) "Equal Weight" Rating Reiterated at Morgan StanleyBruker's (BRKR) "Equal Weight" Rating Reiterated at Morgan Stanley
www.americanbankingnews.com - December 14 at 11:16 AM
Bruker and The Metropolitan Museum of Art Announce Partnership in the Field of Cultural Heritage ScienceBruker and The Metropolitan Museum of Art Announce Partnership in the Field of Cultural Heritage Science
finance.yahoo.com - December 13 at 9:41 AM
ETFs with exposure to Bruker Corp. : December 8, 2017ETFs with exposure to Bruker Corp. : December 8, 2017
finance.yahoo.com - December 8 at 5:18 PM
Bruker Corp. :BRKR-US: Earnings Analysis: Q3, 2017 By the Numbers : December 7, 2017Bruker Corp. :BRKR-US: Earnings Analysis: Q3, 2017 By the Numbers : December 7, 2017
finance.yahoo.com - December 7 at 5:52 PM
Bruker Corp. : BRKR-US: Dividend Analysis : December 04th, 2017 (record date) : By the numbers : December 5, 2017Bruker Corp. : BRKR-US: Dividend Analysis : December 04th, 2017 (record date) : By the numbers : December 5, 2017
finance.yahoo.com - December 5 at 5:21 PM
Bruker Co. (BRKR) Receives Average Rating of "Hold" from AnalystsBruker Co. (BRKR) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - November 30 at 11:46 PM
5 Strong Buy Stocks Gaining Momentum5 Strong Buy Stocks Gaining Momentum
finance.yahoo.com - November 28 at 5:23 PM
Bruker Announces Contract For 133 Hand-Held Chemical Detectors from the U.S. National GuardBruker Announces Contract For 133 Hand-Held Chemical Detectors from the U.S. National Guard
finance.yahoo.com - November 28 at 8:07 AM
Derma Sciences (DSCI) and Bruker Corporation (BRKR) Head to Head SurveyDerma Sciences (DSCI) and Bruker Corporation (BRKR) Head to Head Survey
www.americanbankingnews.com - November 19 at 5:22 AM
 Analysts Expect Bruker Corporation (BRKR) Will Announce Quarterly Sales of $506.92 Million Analysts Expect Bruker Corporation (BRKR) Will Announce Quarterly Sales of $506.92 Million
www.americanbankingnews.com - November 18 at 8:48 AM
Bruker Announces Quarterly DividendBruker Announces Quarterly Dividend
finance.yahoo.com - November 14 at 12:27 AM
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Bruker Corporation (BRKR)SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Bruker Corporation (BRKR)
finance.yahoo.com - November 14 at 12:27 AM
Bruker Corporation Declares Quarterly Dividend of $0.04 (BRKR)Bruker Corporation Declares Quarterly Dividend of $0.04 (BRKR)
www.americanbankingnews.com - November 13 at 1:04 PM
Q3 2018 Earnings Estimate for Bruker Corporation Issued By Jefferies Group (BRKR)Q3 2018 Earnings Estimate for Bruker Corporation Issued By Jefferies Group (BRKR)
www.americanbankingnews.com - November 13 at 7:26 AM
Bruker declares $0.04 dividendBruker declares $0.04 dividend
seekingalpha.com - November 13 at 7:24 AM

SEC Filings

Bruker (NASDAQ:BRKR) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Bruker (NASDAQ:BRKR) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Bruker (NASDAQ BRKR) Stock Chart for Monday, February, 19, 2018

Loading chart…

This page was last updated on 2/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.